logo

For the Inventor, By the Inventor

New Brunswick, NJ, United States of America

David J Riley

This inventor holds 4 USPTO granted patents. Top assignees: University of Medicine and Dentistry of New Jersey, Rutgers, The State University of New Jersey, Other. Active years: 1994-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David J Riley. Retrieved from https://idiyas.com/inventor/david-j-riley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 101(Granted Patents)


Company Filing History:

goldMedal3 out of 272 
 
University of Medicine and Dentistry of New Jersey
 patents
silverMedal2 out of 1,499 
 
Rutgers, The State University of New Jersey
 patents
bronzeMedal1 out of 834,659 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2003

Loading Chart...
4 patents (USPTO):Explore Patents
1. 6517824 - Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor (2003-02-11),
2. 5720950 - Polymers containing antifibrotic agents, compositions containing such (1998-02-24),
3. 5660822 - Polymers containing antifibrotic agents, compositions containing such (1997-08-26),
4. 5372807 - Polymers containing antifibrotic agents, compositions containing such (1994-12-13),

Title: Innovations by David J Riley

Introduction

David J Riley is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of medicine, particularly in the development of antifibrotic agents. With a total of four patents to his name, his work focuses on innovative methods for treating diseases related to collagen metabolism.

Latest Patents

David J Riley's latest patents include groundbreaking advancements in polymer compositions that comprise antifibrotic agents. One of his notable inventions is a method for treating pulmonary hypertension and other diseases involving collagen metabolism defects. This method involves the administration of a liposome encapsulated copolymer conjugate antifibrotic composition. The antifibrotic agent used is preferably a proline analog, such as cis-4-hydroxy-L-proline (cHyp). His innovative approach achieves consistent, high loadings of the antifibrotic agent, which is copolymerized with a polymer component to form an effective delivery system. This method not only facilitates the efficient delivery and rateable release of the antifibrotic agent but also significantly reduces the quantity needed, thereby minimizing potential toxicity from prolonged administration.

Career Highlights

Throughout his career, David J Riley has worked with esteemed institutions such as the University of Medicine and Dentistry of New Jersey and Rutgers, the State University of New Jersey. His research has focused on developing effective treatments for fibrotic conditions, utilizing antifibrotic agents linked to polymers for enhanced delivery and efficacy.

Collaborations

Some of his notable coworkers include George J Poiani and Wei-Chi Liao, who have contributed to his research endeavors and innovations in the field.

Conclusion

David J Riley's contributions to the field of medicine through his innovative patents and research have paved the way for new treatments for fibrotic conditions. His work exemplifies the impact of inventive thinking in addressing complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…